The MoU signifies a strategic collaboration between Oxyle, a pioneering water treatment startup, and Waterleau, a world-leading water technology company. Both companies address the escalating concerns surrounding micropollutants, including pharmaceuticals, pesticides, and particularly per- and polyfluoroalkyl substances (PFAS), in water bodies.

With tightening regulations and growing public pressure, the market for PFAS treatment has seen significant growth, especially in Europe and the US. Waterleau, with its extensive global presence and expertise in water and wastewater treatment, recognizes the urgent need for innovative solutions to tackle these persistent contaminants.

Waterleau adopts a holistic approach to PFAS treatment, recognizing that each PFAS issue is unique and requires a tailored solution. Unlike single solution providers, we prioritize customization to address specific challenges. Oxyle's expertise has enriched the Waterleau PFAS treatment portfolio, now offering comprehensive on-site destruction solutions.

Oxyle brings to the table groundbreaking technology focused on the destruction and mineralization of micropollutants, including a nanoporous catalyst capable of eliminating a broad spectrum of PFAS. Their collaborative approach emphasizes scaling technology and operations, with a keen focus on partnering with industry leaders for rapid market entry.